The duration of diabetes mellitus, the length of dual anti-platelet therapy use and the use of other cardiovascular and oral anti hypoglycemic medications as well as the use of insulin therapy could also have had an effect on the outcomes between male and female patients with diabetes mellitus. This evidence concerns the gene INS and diabetes mellitus.